A fingerprint sweat drug test just won its 8th European patent The new patent links chemical findings to fingerprint residue volume, improving result interpretation and bolstering protection for its drug-testing platform.

#INBS Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

www.stocktitan.net/news/INBS/intelligent-bi...

CELPHEDIA Infrastructure nationale pour les organismes modèles en santé et en recherche biomédicale.

Retrouvez #CELPHEDIA, l' #INBS pour les organismes modèles en santé et en recherche biomédicale, sur le site du GIS IBiSA ➡️ www.ibisa.net/inbs/celphed...

LIPH4SAS Infrastructure nationale dédiée au phénotypage des animaux d’élevage pour la recherche et en faveur de la durabilité de l’élevage.

#LIPH4SAS rejoint l'annuaire des #INBS sur le site du GIS IBiSA ➡️ www.ibisa.net/annuaire-inb... #agroécologie @inrae-france.bsky.social

Fundamental analysis of $INBS (INTELLIGENT BIO SOLUTIONS INC.) based on financial data and reported results.

#INBS

Proteomics french infrastructure (ProFI) Infrastructure nationale de protéomique pour la biologie et la santé.

ProFI Proteomics rejoint les #INBS sur le site d'IBiSA ➡️ www.ibisa.net/inbs/proteom... #protéomique

Breaking News: ( NASDAQ: #INBS ) US Companies Moving the Markets, Morning edition <br>Tue, Jan 06, 2026 as of 10.00 am ET

News; ( NASDAQ: #INBS ) US Companies Moving the Markets, Evening edition <br>Mon, Jan 05, 2026 as of 4:00 pm ET

youtube.com/watch?v=Nhyu... #inbs #INBS $INBS

#INBS won't quit, reaching new highs and holding strong for an afternoon breakout.

Today’s most cited tickers with positive sentiment (last 24h):

#SPY: 19
#TSLA: 11
#BTC: 9
#SLV: 9
#SIDU: 9
#SMX: 9
#QQQ: 7
#SPX: 7
#ONDS: 6
#TLT: 6
#NVDA: 5
#BIDU: 5
#ALCY: 5
#LRE: 5
#UBER: 5
#INBS: 4
#GOOGL: 4
#AAPL: 4

#INBS on fire! Strong long signal triggered, reaching new highs and expecting an afternoon breakout.

📢 Stocks Trending NOW: #IEP #LI #INBS #NKE #BRK-B #ADBE #JNJ #AXSM

Today’s most cited tickers with positive sentiment (last 24h):

#SPY: 24
#ONDS: 12
#SIDU: 12
#INBS: 11
#NKE: 11
#NVDA: 10
#NXXT: 10
#MNTS: 10
#SLV: 9
#TSLA: 9
#SPX: 8
#SLS: 8
#SMX: 8
#AAPL: 8
#GOLD: 7
#ESHA: 6
#BTC: 6
#TLT: 5

Medical test firm secures $10M from healthcare investors Intelligent Bio Solutions sells 2.3M shares and five-year warrants at $4.35 per unit, targeting a Jan. 2 closing and using proceeds for working capital.

#INBS Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

www.stocktitan.net/news/INBS/intelligent-bi...

BREAKING NEWS: ( NASDAQ: #INBS ) Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins Intelligent Bio Solutions (Nasdaq: INBS) announced a strategic manufacturing partnership with Syrma Johari MedTech to scale production of its Intelligent Fingerprinting Drug Screening Reader ahead of planned U.S. market entry in 2026.The collaboration is expected to deliver >40% annual production cost savings, an ~20 percentage‑point improvement in gross margin versus the prior arrangement, and ~4x current manufacturing capacity through Syrma Johari’s 14 facilities and 1.1M+ sq ft footprint. Syrma Johari holds ISO 13485, MDSAP, FDA, TUV SUD, and GMP certifications to support global regulatory needs.

#INBS Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

www.stocktitan.net/news/INBS/intelligent-bi...

Les 27 INBS sont sur le site web du GIS IBiSA

Les #INBS débarquent sur le site web du GIS IBiSA ➡️ www.ibisa.net/inbs/
Vous cherchez une #INBS ? ➡️ www.ibisa.net/annuaire-inbs
Vous cherchez une #Plateforme INBS ? ➡️ www.ibisa.net/plateformes-...
#ClubINBS

Annuaire des INBS Rechercher une infrastructure nationales en biologie et santé

Boostez vos recherches en biologie/santé ! 🧬 27 infrastructures nationales (INBS) ouvertes à tous. Trouvez la vôtre via l’annuaire officiel : www.ibisa.net/annuaire-inbs/

#RechercheScientifique #Biologie #Santé #Innovation #INBS #IBiSA #RechercheCollaborative @ibisa.net

Breaking News: ( NASDAQ: #INBS ) Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring

Intelligent Bio Solutions Inc. Announces Reverse Stock Split Intelligent Bio Solutions (Nasdaq: INBS) will effect a 1‑for‑10 reverse stock split at 11:59 PM ET on December 15, 2025, with split‑adjusted trading resuming on Nasdaq at the open on December 16, 2025 under the symbol INBS and new CUSIP 36151G709.The split was approved by stockholders on October 16, 2025; every 10 shares issued and outstanding will be combined into one share and outstanding equity awards and warrants will be proportionately adjusted. No fractional shares will be issued; holders entitled to fractions will receive a cash payment in lieu of a fractional share. Par value remains $0.01 and authorized shares remain at 100,000,000. Immediately after the reverse split, approximately 959,533 shares will be issued and outstanding.

#INBS Intelligent Bio Solutions Inc. Announces Reverse Stock Split

www.stocktitan.net/news/INBS/intelligent-bi...

L’ #IERP et le #LuMin ont assemblé le premier #microscope français open source à illumination plane sélective, #MesoSPIM, conçu par l'Université de Zurich ➡️ www.ibisa.net/plateformes-... #Mifobio2025 #JST2025 #RMUI @inrae-france.bsky.social, ENS Paris-Saclay, @gdrimabio.bsky.social, #INBS EMERG'IN

Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth Intelligent Bio Solutions (Nasdaq: INBS) reported fiscal 2026 first quarter results for the period ended September 30, 2025, delivering record quarterly revenue of $1,111,797, up 32% sequentially and 28% year‑over‑year. Cartridge consumable sales totaled $640,300, representing 57.59% of revenue. Gross profit margin improved by 690 basis points to 46.6%, attributed to operational efficiency and a higher mix of cartridge sales. The company added 33 net new customer accounts (total active accounts: 492 across 24+ countries), secured a multi‑site contract in London covering 4,400 staff, launched the SmarTest Patch, and signed a global distribution agreement with SMARTOX for markets outside the U.S. and Canada.Management highlighted consumable‑led recurring revenue momentum and margin expansion while advancing toward planned FDA clearance and U.S. market entry.

#INBS Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth

www.stocktitan.net/news/INBS/intelligent-bi...

3D-Hub-S Développement et partage de modèles tumoraux 3D innovants pour explorer le microenvironnement tumoral, harmoniser les approches expérimentales et accélérer la recherche translationnelle en oncologie.

La #plateforme 3D-Hub-S propose son expertise en modélisation 3D des tumeurs et de leur microenvironnement ➡️ www.ibisa.net/plateformes/... @cnrsbiologie.bsky.social, @inserm.fr, @univcotedazur.bsky.social, #INBS ChemBioFrance, #oncologie

Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider Intelligent Bio Solutions (Nasdaq: INBS) announced a major new UK commercial contract on October 23, 2025 with a multinational industrial service provider that employs ~3,000 staff in the UK and Ireland and > 30,000 worldwide. The deployment is described as one of INBS's most significant UK commercial rollouts to date and moves the customer from urine-based third-party testing to INBS's rapid, non-invasive Intelligent Fingerprinting Drug Screening System.The customer expects faster, less disruptive testing, shorter detection windows, improved employee experience, and on-site rapid results. INBS said this supports recurring cartridge revenue and follows prior deployments across transportation, construction, and mining; INBS reports > 480 accounts in 24 countries and 18 distribution partners. The company is pursuing FDA 510(k) clearance to expand U.S. workplace use beyond Forensic Use Only.

#INBS Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

www.stocktitan.net/news/INBS/intelligent-bi...

Intelligent Bio Solutions partnered with us to amplify its growth story.

#INBS shares rose during our campaign period. Though many factors influence #stockperformance, the period also aligned w/ our strategic #investorawareness campaign.

👉 Read more: globalonemedia.com/case-studies...

Record-Breaking 12,500 Units: Intelligent Bio Solutions Hits All-Time High in Drug Test Cartridge Sales Medical tech company ships 519 boxes of drug testing cartridges in July 2025, marking 60% YoY growth. Expansion driven by transportation sector contract win and growing global installed base.

#INBS Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

www.stocktitan.net/news/INBS/intelligent-bi...

Intelligent Bio Solutions ( #Nasdaq: #INBS ) is redefining drug testing with its breakthrough Intelligent Fingerprinting Technology.

Discover how it works, the clinical impact it’s making, and the intellectual property driving its innovation.

📺 Tune in: youtu.be/ZmLPgGdybW8?...

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum Intelligent Bio Solutions (Nasdaq: INBS) announced preliminary fiscal Q4 2025 results, highlighting 16% revenue growth both sequentially and year-over-year. The growth was driven by increased higher-margin cartridge sales and steady account expansion.The company made significant operational progress, including submitting an FDA 510(k) application for its opiate test system for codeine. INBS also completed multilingual upgrades to its Intelligent Fingerprinting Drug Screening System and launched localized websites with enhanced CRM workflows across Europe, the Middle East, and Latin America.Final audited results will be disclosed in the Annual Report on Form 10-K, expected during the week of August 11, 2025.

#INBS Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

www.stocktitan.net/news/INBS/intelligent-bi...

Massive FDA Data Package: Bio Solutions' Drug Test Aims for Quick Approval After 10,000 Hours of Testing New cybersecurity and performance data bolster FDA submission for fingerprint drug test. Response expected in 6 weeks as company eyes multi-billion US market. Learn more.

#INBS Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

www.stocktitan.net/news/INBS/intelligent-bi...